Cacabelos R

References (15)

Title : Pharmacogenomics of Alzheimer's Disease: Novel Strategies for Drug Utilization and Development - Cacabelos_2022_Methods.Mol.Biol_2547_275
Author(s) : Cacabelos R , Naidoo V , Martinez-Iglesias O , Corzo L , Cacabelos N , Pego R , Carril JC
Ref : Methods Mol Biol , 2547 :275 , 2022
Abstract :
PubMedSearch : Cacabelos_2022_Methods.Mol.Biol_2547_275
PubMedID: 36068470

Title : Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer's disease - Cacabelos_2020_Expert.Opin.Drug.Metab.Toxicol_16_673
Author(s) : Cacabelos R
Ref : Expert Opin Drug Metab Toxicol , 16 :673 , 2020
Abstract :
PubMedSearch : Cacabelos_2020_Expert.Opin.Drug.Metab.Toxicol_16_673
PubMedID: 32520597

Title : Novel Therapeutic Strategies for Dementia - Cacabelos_2016_CNS.Neurol.Disord.Drug.Targets_15_141
Author(s) : Cacabelos R , Torrellas C , Carrera I , Cacabelos P , Corzo L , Fernandez-Novoa L , Tellado I , Carril JC , Aliev G
Ref : CNS Neurol Disord Drug Targets , 15 :141 , 2016
Abstract :
PubMedSearch : Cacabelos_2016_CNS.Neurol.Disord.Drug.Targets_15_141
PubMedID: 26831267

Title : Pharmacogenetic considerations in the treatment of Alzheimer's disease - Cacabelos_2016_Pharmacogenomics_17_1041
Author(s) : Cacabelos R , Torrellas C , Teijido O , Carril JC
Ref : Pharmacogenomics , 17 :1041 , 2016
Abstract :
PubMedSearch : Cacabelos_2016_Pharmacogenomics_17_1041
PubMedID: 27291247

Title : Isoxazolotacrines as non-toxic and selective butyrylcholinesterase inhibitors for Alzheimer's disease - Cherif_2014_Future.Med.Chem_6_1883
Author(s) : Cherif O , Allouche F , Chabchoub F , Chioua M , Soriano E , Yanez M , Cacabelos R , Romero A , Lopez MG , Marco-Contelles J
Ref : Future Med Chem , 6 :1883 , 2014
Abstract :
PubMedSearch : Cherif_2014_Future.Med.Chem_6_1883
PubMedID: 25495982

Title : Pharmacogenomics of Alzheimer's disease: novel therapeutic strategies for drug development - Cacabelos_2014_Methods.Mol.Biol_1175_323
Author(s) : Cacabelos R , Cacabelos P , Torrellas C , Tellado I , Carril JC
Ref : Methods Mol Biol , 1175 :323 , 2014
Abstract :
PubMedSearch : Cacabelos_2014_Methods.Mol.Biol_1175_323
PubMedID: 25150875

Title : Combination treatment in Alzheimer's disease: results of a randomized, controlled trial with cerebrolysin and donepezil - Alvarez_2011_Curr.Alzheimer.Res_8_583
Author(s) : Alvarez XA , Cacabelos R , Sampedro C , Couceiro V , Aleixandre M , Vargas M , Linares C , Granizo E , Garcia-Fantini M , Baurecht W , Doppler E , Moessler H
Ref : Curr Alzheimer Res , 8 :583 , 2011
Abstract :
PubMedSearch : Alvarez_2011_Curr.Alzheimer.Res_8_583
PubMedID: 21679156

Title : Genomics and pharmacogenomics of dementia - Cacabelos_2011_CNS.Neurosci.Ther_17_566
Author(s) : Cacabelos R , Martinez-Bouza R
Ref : CNS Neurosci Ther , 17 :566 , 2011
Abstract :
PubMedSearch : Cacabelos_2011_CNS.Neurosci.Ther_17_566
PubMedID: 20718828

Title : Pharmacogenomics and therapeutic prospects in dementia - Cacabelos_2008_Eur.Arch.Psychiatry.Clin.Neurosci_258 Suppl 1_28
Author(s) : Cacabelos R
Ref : European Archives of Psychiatry & Clinical Neuroscience , 258 Suppl 1 :28 , 2008
Abstract :
PubMedSearch : Cacabelos_2008_Eur.Arch.Psychiatry.Clin.Neurosci_258 Suppl 1_28
PubMedID: 18344047

Title : Pharmacogenetic aspects of therapy with cholinesterase inhibitors: the role of CYP2D6 in Alzheimer's disease pharmacogenetics - Cacabelos_2007_Curr.Alzheimer.Res_4_479
Author(s) : Cacabelos R , Llovo R , Fraile C , Fernandez-Novoa L
Ref : Curr Alzheimer Res , 4 :479 , 2007
Abstract :
PubMedSearch : Cacabelos_2007_Curr.Alzheimer.Res_4_479
PubMedID: 17908053

Title : Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease - Cacabelos_2007_Mol.Diagn.Ther_11_385
Author(s) : Cacabelos R
Ref : Mol Diagn Ther , 11 :385 , 2007
Abstract :
PubMedSearch : Cacabelos_2007_Mol.Diagn.Ther_11_385
PubMedID: 18078356

Title : Pharmacogenomics and therapeutic prospects in Alzheimer's disease - Cacabelos_2005_Expert.Opin.Pharmacother_6_1967
Author(s) : Cacabelos R
Ref : Expert Opin Pharmacother , 6 :1967 , 2005
Abstract :
PubMedSearch : Cacabelos_2005_Expert.Opin.Pharmacother_6_1967
PubMedID: 16197352

Title : Pharmacogenomics for the treatment of dementia - Cacabelos_2002_Ann.Med_34_357
Author(s) : Cacabelos R
Ref : Ann Med , 34 :357 , 2002
Abstract :
PubMedSearch : Cacabelos_2002_Ann.Med_34_357
PubMedID: 12452480

Title : Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics - Cacabelos_2000_Drugs.Today.(Barc)_36_415
Author(s) : Cacabelos R , Alvarez A , Lombardi V , Fernandez-Novoa L , Corzo L , Perez P , Laredo M , Pichel V , Hernandez A , Varela M , Figueroa J , Prous J, Jr. , Windisch M , Vigo C
Ref : Drugs Today (Barc) , 36 :415 , 2000
Abstract :
PubMedSearch : Cacabelos_2000_Drugs.Today.(Barc)_36_415
PubMedID: 12861345

Title : Effects of S-9977-2 on histamine levels in rats - Fernandez-Novoa_1996_Meth.Find.Exp.Clin.Pharmacol_18_197
Author(s) : Fernandez-Novoa L , Alvarez XA , Detolle-Sarbach S , Guez D , Zas R , Polo E , Cacabelos R
Ref : Methods Find Exp Clin Pharmacol , 18 :197 , 1996
Abstract :
PubMedSearch : Fernandez-Novoa_1996_Meth.Find.Exp.Clin.Pharmacol_18_197
PubMedID: 8738071